Adrenocorticotropic hormone-dependent Cushing’s syndrome: Use of an octreotide trial to distinguish between pituitary or ectopic sources

Omayma T. El-Shafie, Nooralddin Al-Saffi, Ahmed Al-Sajwani, Nicholas Woodhouse

Research output: Contribution to journalArticle

Abstract

Objectives: Adrenocorticotropic hormone (ACTH) overproduction is usually due to a pituitary tumour which is often not visible on magnetic resonance imaging (MRI). However, ACTH overproduction may be due to an ectopic source. This study aimed to develop a simple non-invasive technique to differentiate these sources. Methods: This study took place in King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, and Sultan Qaboos University Hospital, Muscat, Oman, between 1988 and 2012. Serum cortisol levels were measured in nine patients with ACTH-dependent Cushing’s syndrome before and during a 72-hour trial of octreotide. All patients underwent computed tomography (CT) scans. MRI scans were performed on six patients. Results: CT scans were abnormal in three patients with ectopic ACTH production. MRI scans showed that three patients had pituitary microadenomas. Serum cortisol levels returned to normal in those with confirmed ectopic ACTH production. No response was found in the other six patients. Conclusion: A 72-hour trial of octreotide is recommended for patients with ACTH-dependent Cushing’s syndrome and a normal pituitary MRI. This trial will be a useful alternative to petrosal sinus sampling.

Original languageEnglish
Pages (from-to)120-123
Number of pages4
JournalSultan Qaboos University Medical Journal
Volume15
Issue number1
Publication statusPublished - 2015

Fingerprint

Octreotide
Cushing Syndrome
Adrenocorticotropic Hormone
Ectopic Hormones
Magnetic Resonance Imaging
Hydrocortisone
Petrosal Sinus Sampling
Tomography
Oman
Saudi Arabia
Pituitary Neoplasms
Serum
Research

Keywords

  • Adrenocorticotrophic Hormone
  • Cushing’s Syndrome
  • Investigational Therapies
  • Octreotide
  • Oman
  • Saudi Arabia
  • Somatostatin Receptors

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Adrenocorticotropic hormone-dependent Cushing’s syndrome : Use of an octreotide trial to distinguish between pituitary or ectopic sources. / El-Shafie, Omayma T.; Al-Saffi, Nooralddin; Al-Sajwani, Ahmed; Woodhouse, Nicholas.

In: Sultan Qaboos University Medical Journal, Vol. 15, No. 1, 2015, p. 120-123.

Research output: Contribution to journalArticle

@article{7d80634f79ec4731a088bb03efe68a08,
title = "Adrenocorticotropic hormone-dependent Cushing’s syndrome: Use of an octreotide trial to distinguish between pituitary or ectopic sources",
abstract = "Objectives: Adrenocorticotropic hormone (ACTH) overproduction is usually due to a pituitary tumour which is often not visible on magnetic resonance imaging (MRI). However, ACTH overproduction may be due to an ectopic source. This study aimed to develop a simple non-invasive technique to differentiate these sources. Methods: This study took place in King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, and Sultan Qaboos University Hospital, Muscat, Oman, between 1988 and 2012. Serum cortisol levels were measured in nine patients with ACTH-dependent Cushing’s syndrome before and during a 72-hour trial of octreotide. All patients underwent computed tomography (CT) scans. MRI scans were performed on six patients. Results: CT scans were abnormal in three patients with ectopic ACTH production. MRI scans showed that three patients had pituitary microadenomas. Serum cortisol levels returned to normal in those with confirmed ectopic ACTH production. No response was found in the other six patients. Conclusion: A 72-hour trial of octreotide is recommended for patients with ACTH-dependent Cushing’s syndrome and a normal pituitary MRI. This trial will be a useful alternative to petrosal sinus sampling.",
keywords = "Adrenocorticotrophic Hormone, Cushing’s Syndrome, Investigational Therapies, Octreotide, Oman, Saudi Arabia, Somatostatin Receptors",
author = "El-Shafie, {Omayma T.} and Nooralddin Al-Saffi and Ahmed Al-Sajwani and Nicholas Woodhouse",
year = "2015",
language = "English",
volume = "15",
pages = "120--123",
journal = "Sultan Qaboos University Medical Journal",
issn = "2075-051X",
publisher = "Sultan Qaboos University",
number = "1",

}

TY - JOUR

T1 - Adrenocorticotropic hormone-dependent Cushing’s syndrome

T2 - Use of an octreotide trial to distinguish between pituitary or ectopic sources

AU - El-Shafie, Omayma T.

AU - Al-Saffi, Nooralddin

AU - Al-Sajwani, Ahmed

AU - Woodhouse, Nicholas

PY - 2015

Y1 - 2015

N2 - Objectives: Adrenocorticotropic hormone (ACTH) overproduction is usually due to a pituitary tumour which is often not visible on magnetic resonance imaging (MRI). However, ACTH overproduction may be due to an ectopic source. This study aimed to develop a simple non-invasive technique to differentiate these sources. Methods: This study took place in King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, and Sultan Qaboos University Hospital, Muscat, Oman, between 1988 and 2012. Serum cortisol levels were measured in nine patients with ACTH-dependent Cushing’s syndrome before and during a 72-hour trial of octreotide. All patients underwent computed tomography (CT) scans. MRI scans were performed on six patients. Results: CT scans were abnormal in three patients with ectopic ACTH production. MRI scans showed that three patients had pituitary microadenomas. Serum cortisol levels returned to normal in those with confirmed ectopic ACTH production. No response was found in the other six patients. Conclusion: A 72-hour trial of octreotide is recommended for patients with ACTH-dependent Cushing’s syndrome and a normal pituitary MRI. This trial will be a useful alternative to petrosal sinus sampling.

AB - Objectives: Adrenocorticotropic hormone (ACTH) overproduction is usually due to a pituitary tumour which is often not visible on magnetic resonance imaging (MRI). However, ACTH overproduction may be due to an ectopic source. This study aimed to develop a simple non-invasive technique to differentiate these sources. Methods: This study took place in King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, and Sultan Qaboos University Hospital, Muscat, Oman, between 1988 and 2012. Serum cortisol levels were measured in nine patients with ACTH-dependent Cushing’s syndrome before and during a 72-hour trial of octreotide. All patients underwent computed tomography (CT) scans. MRI scans were performed on six patients. Results: CT scans were abnormal in three patients with ectopic ACTH production. MRI scans showed that three patients had pituitary microadenomas. Serum cortisol levels returned to normal in those with confirmed ectopic ACTH production. No response was found in the other six patients. Conclusion: A 72-hour trial of octreotide is recommended for patients with ACTH-dependent Cushing’s syndrome and a normal pituitary MRI. This trial will be a useful alternative to petrosal sinus sampling.

KW - Adrenocorticotrophic Hormone

KW - Cushing’s Syndrome

KW - Investigational Therapies

KW - Octreotide

KW - Oman

KW - Saudi Arabia

KW - Somatostatin Receptors

UR - http://www.scopus.com/inward/record.url?scp=84922600444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922600444&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84922600444

VL - 15

SP - 120

EP - 123

JO - Sultan Qaboos University Medical Journal

JF - Sultan Qaboos University Medical Journal

SN - 2075-051X

IS - 1

ER -